Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,4999 USD | -1,92 % | -0,22 % | -4,31 % |
Resumen de negocios
Número de empleados: 12
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Brian Strem
CEO | Chief Executive Officer | 44 | 26/07/21 |
Melissa Tosca
DFI | Director of Finance/CFO | 44 | 13/09/22 |
Stefan Sperl
COO | Chief Operating Officer | - | - |
Eric Daniels
PRN | Corporate Officer/Principal | 51 | 21/10/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Praveen Tyle
CHM | Chairman | 64 | 01/06/08 |
Carmine Stengone
BRD | Director/Board Member | 48 | 01/08/23 |
Aron Shapiro
BRD | Director/Board Member | 46 | 01/04/21 |
Kenneth Gayron
BRD | Director/Board Member | 54 | 01/04/21 |
David Hollander
BRD | Director/Board Member | 50 | 13/12/21 |
Brian Strem
CEO | Chief Executive Officer | 44 | 26/07/21 |
Erin Parsons
BRD | Director/Board Member | 48 | 01/02/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 26 256 197 | 26 029 992 ( 99,14 %) | 0 | 99,14 % |
Información de la empresa
Kiora Pharmaceuticals, Inc.
332 Encinitas Boulevard Suite 102
92024, Encinitas
+858 224 9600
http://www.kiorapharma.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-4,31 % | 13,38 M | |
+4,67 % | 111 mil M | |
+11,98 % | 105 mil M | |
-12,82 % | 22,34 mil M | |
-3,70 % | 21,93 mil M | |
-6,03 % | 18,59 mil M | |
-35,21 % | 18,12 mil M | |
-10,19 % | 16,96 mil M | |
+3,74 % | 13,7 mil M | |
+37,48 % | 12,45 mil M |
- Bolsa de valores
- Acciones
- Acción KPRX
- Empresa Kiora Pharmaceuticals, Inc.